Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

CCDC93 Inhibitors

CCDC93 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of CCDC93, a protein involved in cellular processes such as membrane trafficking and endosomal transport. CCDC93 is a coiled-coil domain-containing protein, a structural motif that facilitates protein-protein interactions and contributes to the organization of cellular machinery. This protein is part of a larger complex, often functioning alongside other proteins to mediate the sorting and transport of vesicles between different compartments within the cell, such as the endoplasmic reticulum, Golgi apparatus, and endosomes. Inhibiting CCDC93 disrupts these interactions and impairs vesicular transport, leading to alterations in cellular homeostasis and protein trafficking.

The mechanism by which CCDC93 inhibitors function typically involves binding to the coiled-coil domain or another critical region of the protein, preventing it from interacting with its binding partners and effectively dismantling the protein complexes necessary for proper vesicle transport. By inhibiting CCDC93, these compounds interfere with the cellular logistics of moving proteins and lipids to their intended destinations. Researchers use CCDC93 inhibitors to study the intricacies of intracellular transport and to better understand the role of CCDC93 in coordinating the dynamic processes of vesicle formation, movement, and sorting. These inhibitors provide valuable insights into how defects in membrane trafficking can affect cellular function and highlight the importance of proteins like CCDC93 in maintaining the organization and flow of materials within the cell.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Inhibits the vacuolar-type H+-ATPase (V-ATPase), disrupting endosomal acidification, which can affect CCDC93 function in trafficking.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$87.00
44
(2)

Inhibits dynamin, affecting vesicle scission from the plasma membrane, which can alter endosomal input and CCDC93 activity.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$152.00
$515.00
(1)

Ionophore that disrupts Golgi function, impacting trafficking pathways that can intersect with CCDC93's role.

Pitstop 2

1419093-54-1sc-507418
10 mg
$360.00
(0)

Inhibits clathrin-mediated endocytosis, potentially altering the trafficking routes that CCDC93 is involved in.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Tyrosine kinase inhibitor that can affect signaling pathways and thereby indirectly modify CCDC93-related trafficking.

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$60.00
$108.00
21
(1)

Blocks clathrin-mediated endocytosis, which can impact the endosomal sorting processes involving CCDC93.

Ikarugamycin

36531-78-9sc-202179
500 µg
$185.00
4
(1)

Inhibits clathrin-mediated endocytosis, potentially affecting the endosomal route and CCDC93's role.

5-(N-Ethyl-N-isopropyl)-Amiloride

1154-25-2sc-202458
5 mg
$102.00
20
(1)

Inhibits macropinocytosis, which could change the endocytic trafficking that CCDC93 may regulate.

Filipin III

480-49-9sc-205323
sc-205323A
500 µg
1 mg
$116.00
$145.00
26
(2)

Binds to cholesterol, disrupting lipid rafts and possibly influencing endosomal sorting and CCDC93's activity.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

Destabilizes microtubules, affecting intracellular transport systems that are essential for CCDC93's trafficking role.